SBI Securities’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81 Hold
120
﹤0.01% 3556
2026
Q1
$166 Hold
120
﹤0.01% 3283
2025
Q4
$238 Sell
120
-2
-2% -$7 ﹤0.01% 3156
2025
Q3
$423 Buy
122
+2
+2% +$8 ﹤0.01% 3036
2025
Q2
$517 Hold
120
﹤0.01% 2952
2025
Q1
$356 Hold
120
﹤0.01% 3005
2024
Q4
$710 Buy
+120
New +$494 ﹤0.01% 2756

Other funds holding RKDA

SBI Securities's RKDA Position: Q2 2026 in Review

SBI Securities held its Arcadia Biosciences (RKDA) position steady in Q2 2026 at 120 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

SBI Securities first reported a position in RKDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $710 in Q4 2024. 2 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • SBI Securities held 120 shares of Arcadia Biosciences worth $81 as of Q2 2026.
  • SBI Securities left its Arcadia Biosciences share count unchanged in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3556 holding.
  • SBI Securities first reported a position in Arcadia Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Arcadia Biosciences position peaked at $710 in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.